Liver Directed AAV Gene Therapy Reverses Progression of Glycogen Storage Disease Type IX γ2 in Mice
Conferences
Gibson, RA; Lim, J-A; Choi, SJ; Koch, RL; Bali, D; Young, S; Jeck, W; Sun, B; Asokan, A; Kishnani, PS
Published in: MOLECULAR THERAPY
April 2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 2022
Volume
30
Issue
4
Start / End Page
478 / 479
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics
Citation
APA
Chicago
ICMJE
MLA
NLM
Gibson, R. A., Lim, J.-A., Choi, S. J., Koch, R. L., Bali, D., Young, S., … Kishnani, P. S. (2022). Liver Directed AAV Gene Therapy Reverses Progression of Glycogen Storage Disease Type IX γ2 in Mice. In MOLECULAR THERAPY (Vol. 30, pp. 478–479).
Gibson, Rebecca A., Jeong-A Lim, Su Jin Choi, Rebecca L. Koch, Deeksha Bali, Sarah Young, William Jeck, Baodong Sun, Aravind Asokan, and Priya S. Kishnani. “Liver Directed AAV Gene Therapy Reverses Progression of Glycogen Storage Disease Type IX γ2 in Mice.” In MOLECULAR THERAPY, 30:478–79, 2022.
Gibson RA, Lim J-A, Choi SJ, Koch RL, Bali D, Young S, et al. Liver Directed AAV Gene Therapy Reverses Progression of Glycogen Storage Disease Type IX γ2 in Mice. In: MOLECULAR THERAPY. 2022. p. 478–9.
Gibson, Rebecca A., et al. “Liver Directed AAV Gene Therapy Reverses Progression of Glycogen Storage Disease Type IX γ2 in Mice.” MOLECULAR THERAPY, vol. 30, no. 4, 2022, pp. 478–79.
Gibson RA, Lim J-A, Choi SJ, Koch RL, Bali D, Young S, Jeck W, Sun B, Asokan A, Kishnani PS. Liver Directed AAV Gene Therapy Reverses Progression of Glycogen Storage Disease Type IX γ2 in Mice. MOLECULAR THERAPY. 2022. p. 478–479.
Published In
MOLECULAR THERAPY
EISSN
1525-0024
ISSN
1525-0016
Publication Date
April 2022
Volume
30
Issue
4
Start / End Page
478 / 479
Related Subject Headings
- Biotechnology
- 3206 Medical biotechnology
- 3202 Clinical sciences
- 3105 Genetics